{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:48:27Z","timestamp":1760122107459,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":2692,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.repc.2011.09.014","type":"journal-article","created":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T01:39:46Z","timestamp":1321580386000},"page":"905-924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antithrombotic therapy in nonvalvular atrial fibrillation: A narrative review"],"prefix":"10.1016","volume":"30","author":[{"given":"Susana P.D.","family":"S\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui P.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Santos-Antunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Rocha Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Pedro L.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2011.09.014_bib0005","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2011.09.014_bib0010","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation. The Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2011.09.014_bib0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.ede.0000091649.26364.c0","article-title":"Rising rates of hospital admissions for atrial fibrillation","volume":"14","author":"Friberg","year":"2003","journal-title":"Epidemiology"},{"key":"10.1016\/j.repc.2011.09.014_bib0020","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2011.09.014_bib0025","first-page":"331","article-title":"Preval\u00eancia de fibrilha\u00e7\u00e3o auricular na popula\u00e7\u00e3o portuguesa com 40 ou mais anos. Estudo FAMA","volume":"29","author":"Bonhorst","year":"2010","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repc.2011.09.014_bib0030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.repc.2011.09.014_bib0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ahj.2009.12.043","article-title":"Predicting left atrial thrombi in atrial fibrillation","volume":"159","author":"Wysokinski","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.repc.2011.09.014_bib0040","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/STROKEAHA.107.501825","article-title":"Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation","volume":"39","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.repc.2011.09.014_bib0045","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study","volume":"333","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2011.09.014_bib0055","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"323","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke prevention in atrial fibrillation study. Final results","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2011.09.014_bib0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian Atrial Fibrillation Anticoagulation (CAFA) study","volume":"18","author":"Connolly","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2011.09.014_bib0070","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0075","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2011.09.014_bib0080","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2011.09.014_bib0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2011.09.014_bib0090","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.STR.28.5.1015","article-title":"Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators","volume":"28","author":"Morocutti","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.repc.2011.09.014_bib0095","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.158.14.1513","article-title":"Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation second copenhagen atrial fibrillation, aspirin, and anticoagulation study","volume":"158","author":"Gull\u00f8v","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0100","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archinte.159.12.1322","article-title":"Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation. The AFASAK 2 Study","volume":"159","author":"Gull\u00f8v","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-9149(98)00357-9","article-title":"Effectiveness of fixed minidose warfarin in the prevention of thromboembolic and vascular death in nonrheumatic atrial fibrillation","volume":"82","author":"Pengo","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2011.09.014_bib0110","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/bmj.319.7215.958","article-title":"Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin","volume":"319","author":"Hellemons","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.repc.2011.09.014_bib0115","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.STR.31.4.817","article-title":"Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial","volume":"31","author":"Yamaguchi","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.repc.2011.09.014_bib0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2796.2003.01159.x","article-title":"Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation","volume":"254","author":"Edvardsson","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0125","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2004.05.084","article-title":"Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study","volume":"44","author":"Perez-Gomez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2011.09.014_bib0130","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(03)14841-6","article-title":"Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2011.09.014_bib0135","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jama.293.6.690","article-title":"Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. A randomized trial","volume":"293","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2011.09.014_bib0140","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2011.09.014_bib0145","first-page":"295","article-title":"The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin","volume":"34","author":"Hu","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.repc.2011.09.014_bib0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation treatment of the Aged Study)","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2011.09.014_bib0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ageing\/afl129","article-title":"A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)","volume":"36","author":"Rash","year":"2007","journal-title":"Age Ageing"},{"key":"10.1016\/j.repc.2011.09.014_bib0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(08)60168-3","article-title":"Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2011.09.014_bib0165","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0170","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMc1007378","article-title":"Newly identified events in the RE-LY trial","volume":"363","author":"Connolly","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0175","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(10)61194-4","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2011.09.014_bib0180","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0185","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0190","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jama.279.16.1273","article-title":"Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study","volume":"279","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2011.09.014_bib0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0002-8703(99)70259-0","article-title":"Alternate-day dosing of aspirin in atrial fibrillation","volume":"138","author":"Posada","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.repc.2011.09.014_bib0200","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.STR.0000198839.61112.ee","article-title":"Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial","volume":"37","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.repc.2011.09.014_bib0205","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000118380","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial","volume":"25","author":"Hart","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.repc.2011.09.014_bib0210","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0215","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0220","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0225","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.288.19.2441","article-title":"Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis","volume":"288","author":"Van Walraven","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2011.09.014_bib0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.thromres.2005.08.007","article-title":"Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis","volume":"118","author":"Lip","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.repc.2011.09.014_bib0235","first-page":"CD001925","article-title":"Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks","author":"Aguilar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.repc.2011.09.014_bib0240","first-page":"CD001927","article-title":"Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks","author":"Aguilar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.repc.2011.09.014_bib0245","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bmj.322.7282.321","article-title":"Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation","volume":"322","author":"Taylor","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.repc.2011.09.014_bib0250","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/archinte.1994.00420170093009","article-title":"Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?","volume":"154","author":"Gottlieb","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0255","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.320.7244.1236","article-title":"Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness","volume":"320","author":"Kalra","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.repc.2011.09.014_bib0260","first-page":"493","article-title":"Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice","volume":"161","author":"Caro","year":"1999","journal-title":"CMAJ"},{"key":"10.1016\/j.repc.2011.09.014_bib0265","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archinte.161.11.1443","article-title":"Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?","volume":"161","author":"Evans","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0270","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2011.09.014_bib0275","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0280","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1160\/TH08-08-0499","article-title":"How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database","volume":"101","author":"Rietbrock","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.repc.2011.09.014_bib0285","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2010.01.004","article-title":"Should all patients with non-valvular atrial fibrillation be anticoagulated?","volume":"143","author":"Ederhy","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.repc.2011.09.014_bib0290","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","article-title":"Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators","volume":"30","author":"Hart","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.repc.2011.09.014_bib0295","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/01.STR.19.11.1345","article-title":"Stroke incidence and risk factors for stroke in Copenhagen, Denmark","volume":"19","author":"Boysen","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.repc.2011.09.014_bib0300","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2011.09.014_bib0305","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.jacc.2010.03.009","article-title":"Warfarin genotyping reduces hospitalization rates","volume":"55","author":"Epstein","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2011.09.014_bib0310","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1056\/NEJMp1103050","article-title":"Anticoagulant options \u2013 why the FDA approved a higher but not a lower dose of dabigatran","volume":"364","author":"Beasley","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0315","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJMe1109748","article-title":"A new era for anticoagulation in atrial fibrillation","volume":"365","author":"Mega","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2011.09.014_bib0320","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. The Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.repc.2011.09.014_bib0325","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"pt","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255111000370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255111000370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:59:30Z","timestamp":1760108370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255111000370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0870255111000370"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2011.09.014","relation":{},"ISSN":["0870-2551"],"issn-type":[{"type":"print","value":"0870-2551"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic therapy in nonvalvular atrial fibrillation: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2011.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}